Categories
Change Password!
Reset Password!
Ancient meets Modern: Breakthrough treatment with...
FDA nods for Resmetirom, first-of-its-kind liver s...
Resmetirom is now FDA-approved for non-cirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosi...
Linaclotide found effective for functional constip...
A recent clinical trial in ‘Journal of Pediatric Gastroenterology and Nutrition’ investigated the effectiveness and safety of Li...
Study finds Tegoprazan 50 mg effective for functio...
A recent prospective multicenter clinical trial evaluated the efficacy and safety of tegoprazan, a potassium-competitive acid blocker (P-CAB), in...
Erythrocyte sedimentation rate and C-reactive prot...
Published in the Chinese Journal of Contemporary Pediatrics, this study evaluated the significance of various endoscopic scoring methods for asse...
Exploring potential Hepatitis B treatment choices:...
Rui Liu et al. scrutinized the efficacy of two leading treatments: Tenofovir alafenamide (TAF) and Tenofovir disoproxil fumarate (DF) for chronic...
Vonoprazan-Amoxicillin duo with S. boulardii effec...
Adjunct therapy of Saccharomyces boulardii (S. boulardii) along with Vonoprazan-amoxicillin dual therapy offers new hope for Helicobact...
MRI findings: Obesity linked to liver and kidney f...
Higher body weight or obesity (25 < body mass index (BMI) < 30) plays a crucial role in developing fatty liver and kidney conditions, concl...
Safety and efficacy of Proton-pump inhibitors when...
To assess the effectiveness and safety of the Proton-pump inhibitors (PPIs) + Alginate compared to using PPIs monotherapy for...
Study: Pegbelfermin dosage positively correlates w...
New clinical insights were put forward concerning the appropriate dosing of Pegbelfermin treatment in patients with non-alcoholic steatohepa...
